Atlas Venture Fund XII, L.P. 13D and 13G filings for Jade Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-04-30 4:29 pm Purchase | 2025-04-28 | 13D | Jade Biosciences, Inc. JBIO | Atlas Venture Fund XII, L.P. | 51,406 0.200% | 51,406![]() (New Position) | Filing |